Nuvalent NUVL
NUVL
$123.96 +0.00 (+0.00%)
At close: Jul 21, 2026 · 4:00 PM EDT

Nuvalent (NUVL) Change in Cash (2020 - 2026)

Nuvalent's (NUVL) quarterly Change in Cash came in at -$102.0 million in Q1 2026, down 310.41% YoY from $48.5 million in Q1 2025, and down 169.87% on a QoQ basis from $146.0 million in Q4 2025.

Analysis

Nuvalent (NUVL) Change in Cash (2020 - 2026) Analysis & Trends

Nuvalent (NUVL) has 7 years of Change in Cash data on file, last reported at -$102.0 million in Q1 2026.

  • Quarterly Change in Cash fell 310.41% year-over-year to -$102.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.9 million (up 74.27% YoY) and the FY2025 annual result came in at $116.1 million, up 161.18% from the prior year.
  • Change in Cash fell to -$102.0 million in Q1 2026, from $146.0 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $291.5 million in Q3 2024 to a low of -$236.9 million in Q1 2024.
  • A 5-year average of $5.4 million and a median of -$1.3 million in 2022 frame the typical range for Change in Cash.
  • The widest YoY moves for Change in Cash: up 4312.56% in 2023, down 12006.23% in 2023.
  • Tracing NUVL's Change in Cash over 5 years: stood at $165.5 million in 2022, then soared by 49.22% to $247.0 million in 2023, then slumped by 190.52% to -$223.6 million in 2024, then jumped by 165.31% to $146.0 million in 2025, then tumbled by 169.87% to -$102.0 million in 2026.
  • The last three Change in Cash figures came in at -$102.0 million (Q1 2026), $146.0 million (Q4 2025), and -$11.7 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 649.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.60 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -185.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 427.25 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -2.94 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.42 Mn
10 Nuvalent 9.75 Bn 9.75 Bn - -102.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -102.01 Mn
Dec 31, 2025 145.99 Mn
Sep 30, 2025 -11.72 Mn
Jun 30, 2025 6.64 Mn
Mar 31, 2025 -24.86 Mn
Dec 31, 2024 -223.55 Mn
Sep 30, 2024 291.54 Mn
Jun 30, 2024 -20.82 Mn
Mar 31, 2024 -236.87 Mn
Dec 31, 2023 246.95 Mn
Sep 30, 2023 17.56 Mn
Jun 30, 2023 -19.24 Mn
Mar 31, 2023 -151.69 Mn
Dec 31, 2022 165.49 Mn
Sep 30, 2022 398,000.00
Jun 30, 2022 8.64 Mn
Mar 31, 2022 -1.25 Mn
Dec 31, 2021 -177.36 Mn
Sep 30, 2021 106.97 Mn
Jun 30, 2021 124.52 Mn